Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Free Research Articles

Citations 171-180 of 789 total displayed.

Past content (since May 2004):

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party
Fausto Castagnetti, Francesca Palandri, Marilina Amabile, Nicoletta Testoni, Simona Luatti, Simona Soverini, Ilaria Iacobucci, Massimo Breccia, Giovanna Rege Cambrin, Fabio Stagno, Giorgina Specchia, Piero Galieni, Franco Iuliano, Fabrizio Pane, Giuseppe Saglio, Giuliana Alimena, Giovanni Martinelli, Michele Baccarani, Gianantonio Rosti, and for the GIMEMA CML Working Party
Blood 2009; 113: 3428-3434. [Abstract] [Full text] [PDF]  

Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma
Heinz Ludwig, Roman Hajek, Elena Tóthová, Johannes Drach, Zdenek Adam, Boris Labar, Miklós Egyed, Ivan Spicka, Heinz Gisslinger, Richard Greil, Ingrid Kuhn, Niklas Zojer, and Axel Hinke
Blood 2009; 113: 3435-3442. [Abstract] [Full text] [PDF]  

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program
Michael A. Pulsipher, Pintip Chitphakdithai, John P. Miller, Brent R. Logan, Roberta J. King, J. Douglas Rizzo, Susan F. Leitman, Paolo Anderlini, Michael D. Haagenson, Seira Kurian, John P. Klein, Mary M. Horowitz, and Dennis L. Confer
Blood 2009; 113: 3604-3611. [Abstract] [Full text] [PDF]  

How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation
Raymond Liang
Blood 2009; 113: 3147-3153. [Abstract] [Full text] [PDF]  

Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
Anna Podolanczuk, Alan H. Lazarus, Andrew R. Crow, Elliot Grossbard, and James B. Bussel
Blood 2009; 113: 3154-3160. [Abstract] [Full text] [PDF]  

Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival
Tiffany Ting-Fang Shih, Hsin-An Hou, Chieh-Yu Liu, Bang-Bin Chen, Jih-Luh Tang, Hsuan-Yu Chen, Shwu-Yuan Wei, Ming Yao, Shang-Yi Huang, Wen-Chien Chou, Szu-Chun Hsu, Woei Tsay, Chih-Wei Yu, Chao-Yu Hsu, Hwei-Fang Tien, and Pan-Chyr Yang
Blood 2009; 113: 3161-3167. [Abstract] [Full text] [PDF]  

Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo
Benedetto Bruno, Marcello Rotta, Francesca Patriarca, Daniele Mattei, Bernardino Allione, Fabrizio Carnevale-Schianca, Roberto Sorasio, Alessandro Rambaldi, Marco Casini, Matteo Parma, Pasqua Bavaro, Francesco Onida, Alessandro Busca, Luca Castagna, Edoardo Benedetti, Anna Paola Iori, Luisa Giaccone, Antonio Palumbo, Paolo Corradini, Renato Fanin, David Maloney, Rainer Storb, Ileana Baldi, Umberto Ricardi, and Mario Boccadoro
Blood 2009; 113: 3375-3382. [Abstract] [Full text] [PDF]  

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting
Marcello Rotta, Barry E. Storer, Firoozeh Sahebi, Judith A. Shizuru, Benedetto Bruno, Thoralf Lange, Edward D. Agura, Peter A. McSweeney, Michael A. Pulsipher, Parameswaran Hari, Richard T. Maziarz, Thomas R. Chauncey, Frederick R. Appelbaum, Mohamed L. Sorror, William Bensinger, Brenda M. Sandmaier, Rainer F. Storb, and David G. Maloney
Blood 2009; 113: 3383-3391. [Abstract] [Full text] [PDF]  

D-dimer antigen: current concepts and future prospects
Soheir S. Adam, Nigel S. Key, and Charles S. Greenberg
Blood 2009; 113: 2878-2887. [Abstract] [Full text] [PDF]  

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
Marco Mielcarek, Barry E. Storer, Michael Boeckh, Paul A. Carpenter, George B. McDonald, H. Joachim Deeg, Richard A. Nash, Mary E. D. Flowers, Kristine Doney, Stephanie Lee, Kieren A. Marr, Terry Furlong, Rainer Storb, Frederick R. Appelbaum, and Paul J. Martin
Blood 2009; 113: 2888-2894. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79

* Sign up for Collection Alerts

* Collected Resources Home

* Related collections:
 Special Departments
 ASH 50th Anniversary Reviews
 e-Blood
 Blood Work
 Brief Reports
 Controversies in Hematology
 Focus on Hematology
 Free Research Articles
 How I Treat
 Perspectives
 Plenary Papers
 Review Articles
 Reviews in Translational Hematology

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020